NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Instead, topline typically comes first before publication. You seem to know something about how long this will take ("perhaps many months"), and yet you don’t know. You are guessing. Right now some people have pieced together the impression approximately 233OS data lock, external analysis followed by unblinding. That’s because that is what the company said publicly. Has that changed? Sounds like you think it changed.

You said:

At this stage of the product trial and review, I can assure you that the SEC will be taking a close look at any public communications this company makes. In my experience, company press releases are often "Exhibit A" of shareholder lawsuits.

And your SEC comments seem to be missing the timely issue: The SEC also believe in “timely and full disclosure” of things like “market applications, regulatory status of a clinical research program....”
At least according to A. Ceresney. See article in PharmaExec.com